[go: up one dir, main page]

DE60039441D1 - Tumormarker für frühes krebsstadium - Google Patents

Tumormarker für frühes krebsstadium

Info

Publication number
DE60039441D1
DE60039441D1 DE60039441T DE60039441T DE60039441D1 DE 60039441 D1 DE60039441 D1 DE 60039441D1 DE 60039441 T DE60039441 T DE 60039441T DE 60039441 T DE60039441 T DE 60039441T DE 60039441 D1 DE60039441 D1 DE 60039441D1
Authority
DE
Germany
Prior art keywords
tumormarker
early cancer
stadium
cancer stadium
urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60039441T
Other languages
English (en)
Inventor
Takashi Muramatsu
Kohji Okamoto
Shinya Ikematsu
Munehiro Oda
Hideshi Kumai
Sadatoshi Sakuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anagenics Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60039441D1 publication Critical patent/DE60039441D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60039441T 1999-09-10 2000-09-08 Tumormarker für frühes krebsstadium Expired - Lifetime DE60039441D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP25667899 1999-09-10
JP34540499 1999-12-03
JP2000033168 2000-02-10
PCT/JP2000/006147 WO2001020333A1 (en) 1999-09-10 2000-09-08 Early cancer tumor marker

Publications (1)

Publication Number Publication Date
DE60039441D1 true DE60039441D1 (de) 2008-08-21

Family

ID=27334550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60039441T Expired - Lifetime DE60039441D1 (de) 1999-09-10 2000-09-08 Tumormarker für frühes krebsstadium

Country Status (9)

Country Link
US (1) US7090983B1 (de)
EP (1) EP1215500B1 (de)
KR (1) KR100768985B1 (de)
CN (1) CN1232826C (de)
AT (1) ATE400813T1 (de)
AU (1) AU780957B2 (de)
CA (1) CA2384579C (de)
DE (1) DE60039441D1 (de)
WO (1) WO2001020333A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003301348A1 (en) * 2002-10-18 2004-05-04 Wyeth Compositions and methods for diagnosing and treating autoimmune disease
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
WO2004092992A1 (ja) * 2003-04-15 2004-10-28 Cell Signals Inc. 健康情報の提供システムおよび健康情報の提供方法
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2007053659A2 (en) * 2005-11-01 2007-05-10 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method of screening for hepatocellular carcinoma
AU2006335290A1 (en) 2006-01-11 2007-07-19 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
KR100777088B1 (ko) 2006-04-04 2007-11-28 재단법인 한국원자력의학원 간암을 진단하기 위한 마커인 lcn2, midkine 및tfpi, 그를 포함하는 키트 및 상기 마커를 이용한 간암예측 방법
EP4190448A3 (de) 2006-05-11 2023-09-20 Bio-Rad Laboratories, Inc. Mikrofluidische vorrichtungen
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP3536396B1 (de) 2006-08-07 2022-03-30 The President and Fellows of Harvard College Fluorkohlenstoffemulsionsstabilisierende tenside
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
WO2009025094A1 (ja) * 2007-08-20 2009-02-26 Tsuneya Ohno 哺乳動物の癌の診断方法
JP5580205B2 (ja) * 2007-11-19 2014-08-27 セレラ コーポレーション 肺癌マーカーとその使用
BRPI0907802A2 (pt) * 2008-02-29 2016-08-23 Univ Nagoya Nat Univ Corp biomarcador para lesão renal aguda e estimativa de seu prognóstico, e sua aplicação
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
EP4047367A1 (de) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Verfahren zum nachweis von zielanalyten unter verwendung von tropfenbibliotheken
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US20100221752A2 (en) * 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
JP2010139293A (ja) * 2008-12-10 2010-06-24 Medical Therapies Ltd 早期癌腫瘍マーカー
EP3415235B1 (de) 2009-03-23 2025-11-12 Bio-Rad Laboratories, Inc. Manipulation von mikrofluidiktröpfchen
EP2442106B1 (de) * 2009-06-10 2015-08-19 Masanori Hara Testverfahren auf diabetes-nephropathie
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2517025B1 (de) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
WO2011100604A2 (en) 2010-02-12 2011-08-18 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
JP5905003B2 (ja) 2010-07-09 2016-04-20 ソマロジック・インコーポレーテッド 肺癌バイオマーカーとその使用
KR101857462B1 (ko) 2010-08-13 2018-05-14 소마로직, 인크. 췌장암 바이오마커 및 그것의 용도
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
NZ589251A (en) * 2010-11-12 2014-07-25 Pacific Edge Ltd Novel marker for detection of bladder cancer
EP3859011A1 (de) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Verfahren zur bildung gemischter tröpfchen
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
DE202012013668U1 (de) 2011-06-02 2019-04-18 Raindance Technologies, Inc. Enzymquantifizierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
EP3524693A1 (de) 2012-04-30 2019-08-14 Raindance Technologies, Inc. Digitale analytanalyse
US9946887B2 (en) 2012-06-04 2018-04-17 Nokia Technologies Oy Method and apparatus for determining privacy policy based on data and associated values
CN104956224B (zh) 2012-11-20 2017-12-12 美国政府卫生与公共服务部 测量中期因子或多效生长因子水平用于诊断生长的测定
US20140271453A1 (en) * 2013-03-14 2014-09-18 Abbott Laboratories Methods for the early detection of lung cancer
WO2014172288A2 (en) 2013-04-19 2014-10-23 Raindance Technologies, Inc. Digital analyte analysis
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
CN106461678A (zh) * 2014-05-26 2017-02-22 奥林巴斯株式会社 胰腺癌判定方法
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CN109387635A (zh) * 2018-11-07 2019-02-26 国家纳米科学中心 基于热泳细胞外囊泡检测的胃癌检测系统及方法
KR20220000082U (ko) 2020-07-01 2022-01-10 박세현 곽 휴지 형 그림책

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3418416B2 (ja) * 1992-10-08 2003-06-23 喬 村松 核酸診断法
JP3842304B2 (ja) * 1992-10-08 2006-11-08 喬 村松 癌の診断、治療薬
WO2000031541A2 (en) * 1998-11-20 2000-06-02 Georgetown University Method of detecting neurofibromatosis type 1

Also Published As

Publication number Publication date
AU780957B2 (en) 2005-04-28
EP1215500B1 (de) 2008-07-09
CN1390304A (zh) 2003-01-08
CA2384579C (en) 2010-12-07
CA2384579A1 (en) 2001-03-22
EP1215500A1 (de) 2002-06-19
WO2001020333A1 (en) 2001-03-22
US7090983B1 (en) 2006-08-15
KR100768985B1 (ko) 2007-10-22
EP1215500A4 (de) 2004-12-08
CN1232826C (zh) 2005-12-21
KR20020043577A (ko) 2002-06-10
AU6876000A (en) 2001-04-17
ATE400813T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
DE60039441D1 (de) Tumormarker für frühes krebsstadium
NO20034777L (no) Anordning for måling av blodglukosekonsentrasjoner
NO20011887L (no) Framgangsmåte for ikke-invasiv måling av blod-analytt, med bedret optisk grenseflate
NO20014800D0 (no) Blodsamlesystemer med et integrert fleksibelt filter
SI1535068T1 (sl) Naprave in postopki za odkrivanje amnijske tekočine v vaginalnih izločkih
DE60118511D1 (de) Blutsammelsatz
DE69804761D1 (de) Dreibeinstativ, insbesondere für Photographie
ATE423536T1 (de) Körperstützsystem für patienten
DE60112705D1 (de) Blutsammelsatz
DE59913735D1 (de) Medizinisches rohrschaftinstrument
DK0749582T3 (da) Fremgangsmåde til diagnosticering af præeklampsi
DE60234821D1 (de) Messverfahren für vollblut
NO20051596L (no) Fremgangsmater for a verifisere fluidbevegelse.
ATE496917T1 (de) Haptene, immunogene, antikörper und konjugate für 2-oxo-3-hydroxy lsd
FR2781143B1 (fr) Support expansible a meandres pour un conduit anatomique,en particulier, un vaisseau sanguin
DE69917229D1 (de) Computertomograph mit mehrstufigem integriertem ladungsleseverstärker
FR2795823B1 (fr) Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial
ATE409002T1 (de) Gerät für prostatekrebsdiagnose
DE60313479D1 (de) Vorrichtung zur messung einer optischen weglängenveränderung
AU2002366555A1 (en) Diagnostic for early stage alzheimer's disease
NO20054142L (no) In vitro diagnostisk test for enterovirale infeksjoner
ATE277197T1 (de) Nachweis von harnblasenkarzinom in einer urinprobe
ES2533924T3 (es) Composiciones y métodos para detectar ácidos nucleicos específicos de patógenos en la orina
EP1443326A4 (de) Verfahren zur diagnose eines hirninfarkts
DE50307427D1 (de) Röntgenkassette mit seitlichem Anschlag für den Bildträger

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MEDICAL THERAPIES LTD., SYDNEY, NEW SOUTH WALE, AU

8364 No opposition during term of opposition